nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—Agranulocytosis—Azathioprine—Crohn's disease	0.00144	0.00149	CcSEcCtD
Escitalopram—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00144	0.00149	CcSEcCtD
Escitalopram—Decreased appetite—Mercaptopurine—Crohn's disease	0.00143	0.00149	CcSEcCtD
Escitalopram—Weight increased—Mesalazine—Crohn's disease	0.00143	0.00149	CcSEcCtD
Escitalopram—Weight decreased—Mesalazine—Crohn's disease	0.00142	0.00148	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00142	0.00148	CcSEcCtD
Escitalopram—Leukocytosis—Prednisone—Crohn's disease	0.00141	0.00147	CcSEcCtD
Escitalopram—Pneumonia—Mesalazine—Crohn's disease	0.00141	0.00147	CcSEcCtD
Escitalopram—Infestation NOS—Mesalazine—Crohn's disease	0.0014	0.00146	CcSEcCtD
Escitalopram—Infestation—Mesalazine—Crohn's disease	0.0014	0.00146	CcSEcCtD
Escitalopram—Hypercholesterolaemia—Prednisone—Crohn's disease	0.0014	0.00146	CcSEcCtD
Escitalopram—Depression—Mesalazine—Crohn's disease	0.0014	0.00145	CcSEcCtD
Escitalopram—Cataract—Prednisone—Crohn's disease	0.00139	0.00145	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00139	0.00145	CcSEcCtD
Escitalopram—Haemoglobin—Azathioprine—Crohn's disease	0.00139	0.00144	CcSEcCtD
Escitalopram—Haemorrhage—Azathioprine—Crohn's disease	0.00138	0.00144	CcSEcCtD
Escitalopram—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00137	0.00143	CcSEcCtD
Escitalopram—Stomatitis—Mesalazine—Crohn's disease	0.00137	0.00142	CcSEcCtD
Escitalopram—Jaundice—Mesalazine—Crohn's disease	0.00137	0.00142	CcSEcCtD
Escitalopram—Urinary tract infection—Mesalazine—Crohn's disease	0.00136	0.00142	CcSEcCtD
Escitalopram—Conjunctivitis—Mesalazine—Crohn's disease	0.00136	0.00142	CcSEcCtD
Escitalopram—Sweating—Mesalazine—Crohn's disease	0.00134	0.0014	CcSEcCtD
Escitalopram—Haematuria—Mesalazine—Crohn's disease	0.00134	0.00139	CcSEcCtD
Escitalopram—Hiccups—Prednisone—Crohn's disease	0.00133	0.00138	CcSEcCtD
Escitalopram—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00133	0.00138	CcSEcCtD
Escitalopram—Epistaxis—Mesalazine—Crohn's disease	0.00132	0.00138	CcSEcCtD
Escitalopram—Sinusitis—Mesalazine—Crohn's disease	0.00132	0.00137	CcSEcCtD
Escitalopram—Agranulocytosis—Mesalazine—Crohn's disease	0.00131	0.00136	CcSEcCtD
Escitalopram—Erythema multiforme—Azathioprine—Crohn's disease	0.00131	0.00136	CcSEcCtD
Escitalopram—Body temperature increased—Mercaptopurine—Crohn's disease	0.0013	0.00135	CcSEcCtD
Escitalopram—Haemoglobin—Mesalazine—Crohn's disease	0.00127	0.00132	CcSEcCtD
Escitalopram—Rhinitis—Mesalazine—Crohn's disease	0.00126	0.00131	CcSEcCtD
Escitalopram—Fluid retention—Prednisone—Crohn's disease	0.00126	0.00131	CcSEcCtD
Escitalopram—Haemorrhage—Mesalazine—Crohn's disease	0.00126	0.00131	CcSEcCtD
Escitalopram—Hepatitis—Mesalazine—Crohn's disease	0.00126	0.00131	CcSEcCtD
Escitalopram—Pharyngitis—Mesalazine—Crohn's disease	0.00125	0.0013	CcSEcCtD
Escitalopram—Immune system disorder—Azathioprine—Crohn's disease	0.00125	0.0013	CcSEcCtD
Escitalopram—Mediastinal disorder—Azathioprine—Crohn's disease	0.00125	0.00129	CcSEcCtD
Escitalopram—Neuropathy—Prednisone—Crohn's disease	0.00125	0.00129	CcSEcCtD
Escitalopram—Urinary tract disorder—Mesalazine—Crohn's disease	0.00124	0.00129	CcSEcCtD
Escitalopram—Oedema peripheral—Mesalazine—Crohn's disease	0.00124	0.00129	CcSEcCtD
Escitalopram—Chills—Azathioprine—Crohn's disease	0.00124	0.00129	CcSEcCtD
Escitalopram—Connective tissue disorder—Mesalazine—Crohn's disease	0.00124	0.00129	CcSEcCtD
Escitalopram—Arrhythmia—Azathioprine—Crohn's disease	0.00123	0.00128	CcSEcCtD
Escitalopram—Urethral disorder—Mesalazine—Crohn's disease	0.00123	0.00128	CcSEcCtD
Escitalopram—Alopecia—Azathioprine—Crohn's disease	0.00122	0.00127	CcSEcCtD
Escitalopram—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00121	0.00126	CcSEcCtD
Escitalopram—Oesophagitis—Prednisone—Crohn's disease	0.00121	0.00126	CcSEcCtD
Escitalopram—Ecchymosis—Prednisone—Crohn's disease	0.0012	0.00125	CcSEcCtD
Escitalopram—Erythema multiforme—Mesalazine—Crohn's disease	0.00119	0.00124	CcSEcCtD
Escitalopram—Eye disorder—Mesalazine—Crohn's disease	0.00118	0.00122	CcSEcCtD
Escitalopram—Tinnitus—Mesalazine—Crohn's disease	0.00117	0.00122	CcSEcCtD
Escitalopram—Cardiac disorder—Mesalazine—Crohn's disease	0.00117	0.00121	CcSEcCtD
Escitalopram—Hyperkinesia—Prednisone—Crohn's disease	0.00116	0.0012	CcSEcCtD
Escitalopram—Sepsis—Prednisone—Crohn's disease	0.00115	0.0012	CcSEcCtD
Escitalopram—Angiopathy—Mesalazine—Crohn's disease	0.00114	0.00119	CcSEcCtD
Escitalopram—Euphoric mood—Prednisone—Crohn's disease	0.00114	0.00118	CcSEcCtD
Escitalopram—Immune system disorder—Mesalazine—Crohn's disease	0.00114	0.00118	CcSEcCtD
Escitalopram—Mediastinal disorder—Mesalazine—Crohn's disease	0.00113	0.00118	CcSEcCtD
Escitalopram—Chills—Mesalazine—Crohn's disease	0.00113	0.00117	CcSEcCtD
Escitalopram—Diarrhoea—Mercaptopurine—Crohn's disease	0.00113	0.00117	CcSEcCtD
Escitalopram—Ill-defined disorder—Azathioprine—Crohn's disease	0.00112	0.00116	CcSEcCtD
Escitalopram—Alopecia—Mesalazine—Crohn's disease	0.00111	0.00116	CcSEcCtD
Escitalopram—Anaemia—Azathioprine—Crohn's disease	0.00111	0.00116	CcSEcCtD
Escitalopram—Diabetes mellitus—Prednisone—Crohn's disease	0.00111	0.00115	CcSEcCtD
Escitalopram—Mental disorder—Mesalazine—Crohn's disease	0.0011	0.00115	CcSEcCtD
Escitalopram—Erythema—Mesalazine—Crohn's disease	0.0011	0.00114	CcSEcCtD
Escitalopram—Malaise—Azathioprine—Crohn's disease	0.00109	0.00113	CcSEcCtD
Escitalopram—Flatulence—Mesalazine—Crohn's disease	0.00108	0.00112	CcSEcCtD
Escitalopram—Leukopenia—Azathioprine—Crohn's disease	0.00108	0.00112	CcSEcCtD
Escitalopram—Vascular purpura—Prednisone—Crohn's disease	0.00108	0.00112	CcSEcCtD
Escitalopram—Tension—Mesalazine—Crohn's disease	0.00108	0.00112	CcSEcCtD
Escitalopram—Dysgeusia—Mesalazine—Crohn's disease	0.00107	0.00112	CcSEcCtD
Escitalopram—Nervousness—Mesalazine—Crohn's disease	0.00106	0.00111	CcSEcCtD
Escitalopram—Back pain—Mesalazine—Crohn's disease	0.00106	0.0011	CcSEcCtD
Escitalopram—Muscle spasms—Mesalazine—Crohn's disease	0.00105	0.0011	CcSEcCtD
Escitalopram—Vomiting—Mercaptopurine—Crohn's disease	0.00105	0.00109	CcSEcCtD
Escitalopram—Injury—Prednisone—Crohn's disease	0.00105	0.00109	CcSEcCtD
Escitalopram—Rash—Mercaptopurine—Crohn's disease	0.00104	0.00108	CcSEcCtD
Escitalopram—Dermatitis—Mercaptopurine—Crohn's disease	0.00104	0.00108	CcSEcCtD
Escitalopram—Vision blurred—Mesalazine—Crohn's disease	0.00103	0.00107	CcSEcCtD
Escitalopram—Tremor—Mesalazine—Crohn's disease	0.00103	0.00107	CcSEcCtD
Escitalopram—Increased appetite—Prednisone—Crohn's disease	0.00102	0.00107	CcSEcCtD
Escitalopram—Amnesia—Prednisone—Crohn's disease	0.00102	0.00107	CcSEcCtD
Escitalopram—Arthralgia—Azathioprine—Crohn's disease	0.00102	0.00106	CcSEcCtD
Escitalopram—Myalgia—Azathioprine—Crohn's disease	0.00102	0.00106	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00102	0.00106	CcSEcCtD
Escitalopram—Ill-defined disorder—Mesalazine—Crohn's disease	0.00102	0.00106	CcSEcCtD
Escitalopram—Anaemia—Mesalazine—Crohn's disease	0.00101	0.00105	CcSEcCtD
Escitalopram—Discomfort—Azathioprine—Crohn's disease	0.00101	0.00105	CcSEcCtD
Escitalopram—Angioedema—Mesalazine—Crohn's disease	0.001	0.00104	CcSEcCtD
Escitalopram—Purpura—Prednisone—Crohn's disease	0.000999	0.00104	CcSEcCtD
Escitalopram—Malaise—Mesalazine—Crohn's disease	0.000988	0.00103	CcSEcCtD
Escitalopram—Cardiac failure—Prednisone—Crohn's disease	0.000987	0.00103	CcSEcCtD
Escitalopram—Vertigo—Mesalazine—Crohn's disease	0.000985	0.00102	CcSEcCtD
Escitalopram—Syncope—Mesalazine—Crohn's disease	0.000983	0.00102	CcSEcCtD
Escitalopram—Lethargy—Prednisone—Crohn's disease	0.000983	0.00102	CcSEcCtD
Escitalopram—Leukopenia—Mesalazine—Crohn's disease	0.000981	0.00102	CcSEcCtD
Escitalopram—Nausea—Mercaptopurine—Crohn's disease	0.000979	0.00102	CcSEcCtD
Escitalopram—Infection—Azathioprine—Crohn's disease	0.000976	0.00101	CcSEcCtD
Escitalopram—Palpitations—Mesalazine—Crohn's disease	0.000969	0.00101	CcSEcCtD
Escitalopram—Loss of consciousness—Mesalazine—Crohn's disease	0.000963	0.001	CcSEcCtD
Escitalopram—Osteoarthritis—Prednisone—Crohn's disease	0.000963	0.001	CcSEcCtD
Escitalopram—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000963	0.001	CcSEcCtD
Escitalopram—Thrombocytopenia—Azathioprine—Crohn's disease	0.000961	0.000999	CcSEcCtD
Escitalopram—Cough—Mesalazine—Crohn's disease	0.000956	0.000994	CcSEcCtD
Escitalopram—Skin disorder—Azathioprine—Crohn's disease	0.000954	0.000992	CcSEcCtD
Escitalopram—Affect lability—Prednisone—Crohn's disease	0.000948	0.000985	CcSEcCtD
Escitalopram—Hypertension—Mesalazine—Crohn's disease	0.000946	0.000984	CcSEcCtD
Escitalopram—Psychotic disorder—Prednisone—Crohn's disease	0.00094	0.000978	CcSEcCtD
Escitalopram—Chest pain—Mesalazine—Crohn's disease	0.000933	0.00097	CcSEcCtD
Escitalopram—Arthralgia—Mesalazine—Crohn's disease	0.000933	0.00097	CcSEcCtD
Escitalopram—Myalgia—Mesalazine—Crohn's disease	0.000933	0.00097	CcSEcCtD
Escitalopram—Anxiety—Mesalazine—Crohn's disease	0.00093	0.000967	CcSEcCtD
Escitalopram—Face oedema—Prednisone—Crohn's disease	0.00093	0.000966	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000927	0.000963	CcSEcCtD
Escitalopram—Discomfort—Mesalazine—Crohn's disease	0.000922	0.000958	CcSEcCtD
Escitalopram—Irritability—Prednisone—Crohn's disease	0.000919	0.000955	CcSEcCtD
Escitalopram—Hypotension—Azathioprine—Crohn's disease	0.000918	0.000954	CcSEcCtD
Escitalopram—Cardiac arrest—Prednisone—Crohn's disease	0.000916	0.000952	CcSEcCtD
Escitalopram—Dry mouth—Mesalazine—Crohn's disease	0.000913	0.000949	CcSEcCtD
Escitalopram—Mood swings—Prednisone—Crohn's disease	0.000912	0.000948	CcSEcCtD
Escitalopram—Confusional state—Mesalazine—Crohn's disease	0.000902	0.000938	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000895	0.00093	CcSEcCtD
Escitalopram—Anaphylactic shock—Mesalazine—Crohn's disease	0.000894	0.00093	CcSEcCtD
Escitalopram—Oedema—Mesalazine—Crohn's disease	0.000894	0.00093	CcSEcCtD
Escitalopram—Infection—Mesalazine—Crohn's disease	0.000889	0.000924	CcSEcCtD
Escitalopram—Dry skin—Prednisone—Crohn's disease	0.000883	0.000917	CcSEcCtD
Escitalopram—Shock—Mesalazine—Crohn's disease	0.00088	0.000915	CcSEcCtD
Escitalopram—Nervous system disorder—Mesalazine—Crohn's disease	0.000877	0.000912	CcSEcCtD
Escitalopram—Hypokalaemia—Prednisone—Crohn's disease	0.000876	0.000911	CcSEcCtD
Escitalopram—Thrombocytopenia—Mesalazine—Crohn's disease	0.000876	0.00091	CcSEcCtD
Escitalopram—Tachycardia—Mesalazine—Crohn's disease	0.000873	0.000907	CcSEcCtD
Escitalopram—Skin disorder—Mesalazine—Crohn's disease	0.000869	0.000903	CcSEcCtD
Escitalopram—Hyperhidrosis—Mesalazine—Crohn's disease	0.000865	0.000899	CcSEcCtD
Escitalopram—Anorexia—Mesalazine—Crohn's disease	0.000853	0.000886	CcSEcCtD
Escitalopram—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000849	0.000883	CcSEcCtD
Escitalopram—Muscular weakness—Prednisone—Crohn's disease	0.000849	0.000883	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000848	0.000881	CcSEcCtD
Escitalopram—Abdominal distension—Prednisone—Crohn's disease	0.000838	0.000871	CcSEcCtD
Escitalopram—Hypotension—Mesalazine—Crohn's disease	0.000836	0.000869	CcSEcCtD
Escitalopram—Pancreatitis—Prednisone—Crohn's disease	0.000816	0.000848	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000815	0.000847	CcSEcCtD
Escitalopram—Sweating increased—Prednisone—Crohn's disease	0.000811	0.000843	CcSEcCtD
Escitalopram—Feeling abnormal—Azathioprine—Crohn's disease	0.000809	0.000841	CcSEcCtD
Escitalopram—Insomnia—Mesalazine—Crohn's disease	0.000809	0.000841	CcSEcCtD
Escitalopram—Paraesthesia—Mesalazine—Crohn's disease	0.000803	0.000835	CcSEcCtD
Escitalopram—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000803	0.000835	CcSEcCtD
Escitalopram—Dyspnoea—Mesalazine—Crohn's disease	0.000797	0.000829	CcSEcCtD
Escitalopram—Somnolence—Mesalazine—Crohn's disease	0.000795	0.000827	CcSEcCtD
Escitalopram—Dyspepsia—Mesalazine—Crohn's disease	0.000787	0.000818	CcSEcCtD
Escitalopram—Decreased appetite—Mesalazine—Crohn's disease	0.000778	0.000808	CcSEcCtD
Escitalopram—Body temperature increased—Azathioprine—Crohn's disease	0.000776	0.000807	CcSEcCtD
Escitalopram—Abdominal pain—Azathioprine—Crohn's disease	0.000776	0.000807	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000772	0.000803	CcSEcCtD
Escitalopram—Fatigue—Mesalazine—Crohn's disease	0.000771	0.000802	CcSEcCtD
Escitalopram—Erectile dysfunction—Prednisone—Crohn's disease	0.000766	0.000797	CcSEcCtD
Escitalopram—Pain—Mesalazine—Crohn's disease	0.000765	0.000795	CcSEcCtD
Escitalopram—Constipation—Mesalazine—Crohn's disease	0.000765	0.000795	CcSEcCtD
Escitalopram—Weight increased—Prednisone—Crohn's disease	0.000757	0.000787	CcSEcCtD
Escitalopram—Weight decreased—Prednisone—Crohn's disease	0.000753	0.000783	CcSEcCtD
Escitalopram—Hyperglycaemia—Prednisone—Crohn's disease	0.000751	0.00078	CcSEcCtD
Escitalopram—Depression—Prednisone—Crohn's disease	0.00074	0.000769	CcSEcCtD
Escitalopram—Feeling abnormal—Mesalazine—Crohn's disease	0.000737	0.000766	CcSEcCtD
Escitalopram—Acute coronary syndrome—Prednisone—Crohn's disease	0.000731	0.00076	CcSEcCtD
Escitalopram—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000731	0.00076	CcSEcCtD
Escitalopram—Neuropathy peripheral—Prednisone—Crohn's disease	0.000727	0.000756	CcSEcCtD
Escitalopram—Myocardial infarction—Prednisone—Crohn's disease	0.000727	0.000756	CcSEcCtD
Escitalopram—Hypersensitivity—Azathioprine—Crohn's disease	0.000723	0.000752	CcSEcCtD
Escitalopram—Urticaria—Mesalazine—Crohn's disease	0.000711	0.000739	CcSEcCtD
Escitalopram—Body temperature increased—Mesalazine—Crohn's disease	0.000707	0.000735	CcSEcCtD
Escitalopram—Abdominal pain—Mesalazine—Crohn's disease	0.000707	0.000735	CcSEcCtD
Escitalopram—Bradycardia—Prednisone—Crohn's disease	0.000678	0.000705	CcSEcCtD
Escitalopram—Diarrhoea—Azathioprine—Crohn's disease	0.000672	0.000698	CcSEcCtD
Escitalopram—Haemoglobin—Prednisone—Crohn's disease	0.000669	0.000696	CcSEcCtD
Escitalopram—Haemorrhage—Prednisone—Crohn's disease	0.000666	0.000692	CcSEcCtD
Escitalopram—Hallucination—Prednisone—Crohn's disease	0.000663	0.000689	CcSEcCtD
Escitalopram—Hypersensitivity—Mesalazine—Crohn's disease	0.000659	0.000685	CcSEcCtD
Escitalopram—Connective tissue disorder—Prednisone—Crohn's disease	0.000655	0.00068	CcSEcCtD
Escitalopram—Dizziness—Azathioprine—Crohn's disease	0.000649	0.000675	CcSEcCtD
Escitalopram—Asthenia—Mesalazine—Crohn's disease	0.000642	0.000667	CcSEcCtD
Escitalopram—Pruritus—Mesalazine—Crohn's disease	0.000633	0.000658	CcSEcCtD
Escitalopram—Vomiting—Azathioprine—Crohn's disease	0.000624	0.000649	CcSEcCtD
Escitalopram—Eye disorder—Prednisone—Crohn's disease	0.000622	0.000647	CcSEcCtD
Escitalopram—Rash—Azathioprine—Crohn's disease	0.000619	0.000644	CcSEcCtD
Escitalopram—Dermatitis—Azathioprine—Crohn's disease	0.000619	0.000643	CcSEcCtD
Escitalopram—Flushing—Prednisone—Crohn's disease	0.000618	0.000643	CcSEcCtD
Escitalopram—Headache—Azathioprine—Crohn's disease	0.000615	0.000639	CcSEcCtD
Escitalopram—Diarrhoea—Mesalazine—Crohn's disease	0.000612	0.000636	CcSEcCtD
Escitalopram—Angiopathy—Prednisone—Crohn's disease	0.000604	0.000628	CcSEcCtD
Escitalopram—Immune system disorder—Prednisone—Crohn's disease	0.000602	0.000625	CcSEcCtD
Escitalopram—Arrhythmia—Prednisone—Crohn's disease	0.000595	0.000619	CcSEcCtD
Escitalopram—Dizziness—Mesalazine—Crohn's disease	0.000591	0.000615	CcSEcCtD
Escitalopram—Alopecia—Prednisone—Crohn's disease	0.000589	0.000612	CcSEcCtD
Escitalopram—Mental disorder—Prednisone—Crohn's disease	0.000584	0.000607	CcSEcCtD
Escitalopram—Nausea—Azathioprine—Crohn's disease	0.000583	0.000606	CcSEcCtD
Escitalopram—Erythema—Prednisone—Crohn's disease	0.00058	0.000603	CcSEcCtD
Escitalopram—Malnutrition—Prednisone—Crohn's disease	0.00058	0.000603	CcSEcCtD
Escitalopram—Vomiting—Mesalazine—Crohn's disease	0.000569	0.000591	CcSEcCtD
Escitalopram—Rash—Mesalazine—Crohn's disease	0.000564	0.000586	CcSEcCtD
Escitalopram—Dermatitis—Mesalazine—Crohn's disease	0.000563	0.000586	CcSEcCtD
Escitalopram—Headache—Mesalazine—Crohn's disease	0.00056	0.000583	CcSEcCtD
Escitalopram—Vision blurred—Prednisone—Crohn's disease	0.000546	0.000568	CcSEcCtD
Escitalopram—Ill-defined disorder—Prednisone—Crohn's disease	0.000538	0.000559	CcSEcCtD
Escitalopram—Anaemia—Prednisone—Crohn's disease	0.000536	0.000557	CcSEcCtD
Escitalopram—Agitation—Prednisone—Crohn's disease	0.000533	0.000554	CcSEcCtD
Escitalopram—Nausea—Mesalazine—Crohn's disease	0.000531	0.000552	CcSEcCtD
Escitalopram—Angioedema—Prednisone—Crohn's disease	0.00053	0.000551	CcSEcCtD
Escitalopram—Malaise—Prednisone—Crohn's disease	0.000523	0.000544	CcSEcCtD
Escitalopram—Vertigo—Prednisone—Crohn's disease	0.000521	0.000542	CcSEcCtD
Escitalopram—Syncope—Prednisone—Crohn's disease	0.00052	0.000541	CcSEcCtD
Escitalopram—Loss of consciousness—Prednisone—Crohn's disease	0.00051	0.00053	CcSEcCtD
Escitalopram—Convulsion—Prednisone—Crohn's disease	0.000502	0.000522	CcSEcCtD
Escitalopram—Hypertension—Prednisone—Crohn's disease	0.000501	0.00052	CcSEcCtD
Escitalopram—Arthralgia—Prednisone—Crohn's disease	0.000494	0.000513	CcSEcCtD
Escitalopram—Myalgia—Prednisone—Crohn's disease	0.000494	0.000513	CcSEcCtD
Escitalopram—Anxiety—Prednisone—Crohn's disease	0.000492	0.000511	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00049	0.00051	CcSEcCtD
Escitalopram—Discomfort—Prednisone—Crohn's disease	0.000488	0.000507	CcSEcCtD
Escitalopram—Anaphylactic shock—Prednisone—Crohn's disease	0.000473	0.000492	CcSEcCtD
Escitalopram—Oedema—Prednisone—Crohn's disease	0.000473	0.000492	CcSEcCtD
Escitalopram—Infection—Prednisone—Crohn's disease	0.00047	0.000489	CcSEcCtD
Escitalopram—Shock—Prednisone—Crohn's disease	0.000466	0.000484	CcSEcCtD
Escitalopram—Nervous system disorder—Prednisone—Crohn's disease	0.000464	0.000482	CcSEcCtD
Escitalopram—Tachycardia—Prednisone—Crohn's disease	0.000462	0.00048	CcSEcCtD
Escitalopram—Skin disorder—Prednisone—Crohn's disease	0.00046	0.000478	CcSEcCtD
Escitalopram—Hyperhidrosis—Prednisone—Crohn's disease	0.000457	0.000476	CcSEcCtD
Escitalopram—Anorexia—Prednisone—Crohn's disease	0.000451	0.000469	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000431	0.000448	CcSEcCtD
Escitalopram—Insomnia—Prednisone—Crohn's disease	0.000428	0.000445	CcSEcCtD
Escitalopram—Paraesthesia—Prednisone—Crohn's disease	0.000425	0.000442	CcSEcCtD
Escitalopram—Dyspepsia—Prednisone—Crohn's disease	0.000417	0.000433	CcSEcCtD
Escitalopram—Decreased appetite—Prednisone—Crohn's disease	0.000411	0.000428	CcSEcCtD
Escitalopram—Fatigue—Prednisone—Crohn's disease	0.000408	0.000424	CcSEcCtD
Escitalopram—Constipation—Prednisone—Crohn's disease	0.000405	0.000421	CcSEcCtD
Escitalopram—Feeling abnormal—Prednisone—Crohn's disease	0.00039	0.000405	CcSEcCtD
Escitalopram—Gastrointestinal pain—Prednisone—Crohn's disease	0.000387	0.000402	CcSEcCtD
Escitalopram—Urticaria—Prednisone—Crohn's disease	0.000376	0.000391	CcSEcCtD
Escitalopram—Abdominal pain—Prednisone—Crohn's disease	0.000374	0.000389	CcSEcCtD
Escitalopram—Body temperature increased—Prednisone—Crohn's disease	0.000374	0.000389	CcSEcCtD
Escitalopram—Hypersensitivity—Prednisone—Crohn's disease	0.000349	0.000362	CcSEcCtD
Escitalopram—Asthenia—Prednisone—Crohn's disease	0.00034	0.000353	CcSEcCtD
Escitalopram—Pruritus—Prednisone—Crohn's disease	0.000335	0.000348	CcSEcCtD
Escitalopram—Diarrhoea—Prednisone—Crohn's disease	0.000324	0.000337	CcSEcCtD
Escitalopram—Dizziness—Prednisone—Crohn's disease	0.000313	0.000325	CcSEcCtD
Escitalopram—Vomiting—Prednisone—Crohn's disease	0.000301	0.000313	CcSEcCtD
Escitalopram—Rash—Prednisone—Crohn's disease	0.000298	0.00031	CcSEcCtD
Escitalopram—Dermatitis—Prednisone—Crohn's disease	0.000298	0.00031	CcSEcCtD
Escitalopram—Headache—Prednisone—Crohn's disease	0.000296	0.000308	CcSEcCtD
Escitalopram—Nausea—Prednisone—Crohn's disease	0.000281	0.000292	CcSEcCtD
Escitalopram—HRH1—GPCR downstream signaling—MLN—Crohn's disease	9.92e-05	0.00261	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	9.91e-05	0.0026	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—MLN—Crohn's disease	9.89e-05	0.0026	CbGpPWpGaD
Escitalopram—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	9.85e-05	0.00259	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—MLN—Crohn's disease	9.73e-05	0.00256	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—IL1B—Crohn's disease	9.51e-05	0.0025	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—ACKR2—Crohn's disease	9.5e-05	0.0025	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—ACKR2—Crohn's disease	9.47e-05	0.00249	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.44e-05	0.00248	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.42e-05	0.00248	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—ACKR2—Crohn's disease	9.32e-05	0.00245	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	9.32e-05	0.00245	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CCR6—Crohn's disease	9.3e-05	0.00244	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	9.29e-05	0.00244	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	9.14e-05	0.0024	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—MLN—Crohn's disease	9.01e-05	0.00237	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—MLN—Crohn's disease	8.98e-05	0.00236	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—MLN—Crohn's disease	8.84e-05	0.00232	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.44e-05	0.00222	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.35e-05	0.00219	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—PTGER4—Crohn's disease	8.19e-05	0.00215	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	8.09e-05	0.00212	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CCR6—Crohn's disease	8.06e-05	0.00212	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CCR6—Crohn's disease	8.03e-05	0.00211	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CCR9—Crohn's disease	7.93e-05	0.00208	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CCR6—Crohn's disease	7.91e-05	0.00208	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—GPR65—Crohn's disease	7.38e-05	0.00194	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCR9—Crohn's disease	7.2e-05	0.00189	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.18e-05	0.00189	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—PTGER4—Crohn's disease	7.09e-05	0.00186	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	7.07e-05	0.00186	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—PTGER4—Crohn's disease	6.96e-05	0.00183	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—TNF—Crohn's disease	6.9e-05	0.00181	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CCR9—Crohn's disease	6.87e-05	0.00181	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	6.85e-05	0.0018	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CCR9—Crohn's disease	6.75e-05	0.00177	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—GPR65—Crohn's disease	6.7e-05	0.00176	CbGpPWpGaD
Escitalopram—SLC6A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.67e-05	0.00175	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ACKR2—Crohn's disease	6.48e-05	0.0017	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—GPR65—Crohn's disease	6.39e-05	0.00168	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	6.37e-05	0.00167	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—GPR65—Crohn's disease	6.27e-05	0.00165	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCR9—Crohn's disease	6.24e-05	0.00164	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	6.22e-05	0.00164	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MLN—Crohn's disease	6.14e-05	0.00161	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCR9—Crohn's disease	6.13e-05	0.00161	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	6.1e-05	0.0016	CbGpPWpGaD
Escitalopram—SLC6A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.91e-05	0.00155	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	5.82e-05	0.00153	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—GPR65—Crohn's disease	5.8e-05	0.00152	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	5.79e-05	0.00152	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—GPR65—Crohn's disease	5.7e-05	0.0015	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TAGAP—Crohn's disease	5.62e-05	0.00148	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ACKR2—Crohn's disease	5.61e-05	0.00147	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	5.59e-05	0.00147	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.59e-05	0.00147	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—IL6—Crohn's disease	5.57e-05	0.00146	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ACKR2—Crohn's disease	5.51e-05	0.00145	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MLN—Crohn's disease	5.32e-05	0.0014	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MLN—Crohn's disease	5.3e-05	0.00139	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	5.29e-05	0.00139	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	5.27e-05	0.00139	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CCR6—Crohn's disease	5.26e-05	0.00138	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.24e-05	0.00138	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MLN—Crohn's disease	5.22e-05	0.00137	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	5.19e-05	0.00136	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	5.05e-05	0.00133	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	5.03e-05	0.00132	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	4.95e-05	0.0013	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RSPO3—Crohn's disease	4.91e-05	0.00129	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TAGAP—Crohn's disease	4.87e-05	0.00128	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	4.85e-05	0.00127	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	4.78e-05	0.00125	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCR6—Crohn's disease	4.77e-05	0.00125	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SEL1L—Crohn's disease	4.65e-05	0.00122	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—PTGER4—Crohn's disease	4.63e-05	0.00122	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CCR6—Crohn's disease	4.55e-05	0.0012	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—IL6—Crohn's disease	4.55e-05	0.00119	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	4.54e-05	0.00119	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	4.47e-05	0.00117	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCR9—Crohn's disease	4.26e-05	0.00112	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RSPO3—Crohn's disease	4.25e-05	0.00112	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	4.24e-05	0.00111	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PTGER4—Crohn's disease	4.2e-05	0.0011	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	4.17e-05	0.0011	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCR6—Crohn's disease	4.14e-05	0.00109	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	4.12e-05	0.00108	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	4.06e-05	0.00107	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SEL1L—Crohn's disease	4.03e-05	0.00106	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	4.02e-05	0.00106	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—PTGER4—Crohn's disease	4.01e-05	0.00105	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	4e-05	0.00105	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	3.96e-05	0.00104	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GPR65—Crohn's disease	3.96e-05	0.00104	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—IL3—Crohn's disease	3.94e-05	0.00104	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.94e-05	0.00103	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	3.93e-05	0.00103	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—RASGRP1—Crohn's disease	3.81e-05	0.001	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	3.76e-05	0.000988	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR9—Crohn's disease	3.69e-05	0.000969	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR9—Crohn's disease	3.68e-05	0.000966	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	3.64e-05	0.000957	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	3.63e-05	0.000954	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	3.62e-05	0.000951	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL3—Crohn's disease	3.58e-05	0.00094	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	3.57e-05	0.000939	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—RASGRP1—Crohn's disease	3.46e-05	0.00091	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	3.46e-05	0.000908	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GPR65—Crohn's disease	3.43e-05	0.000901	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GPR65—Crohn's disease	3.42e-05	0.000898	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—IL3—Crohn's disease	3.41e-05	0.000897	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.41e-05	0.000896	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	3.4e-05	0.000894	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.4e-05	0.000893	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.39e-05	0.000891	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	3.36e-05	0.000884	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	3.35e-05	0.00088	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.35e-05	0.000879	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	3.3e-05	0.000868	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	3.29e-05	0.000865	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	3.24e-05	0.000852	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTMR3—Crohn's disease	3.2e-05	0.00084	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL3—Crohn's disease	3.1e-05	0.000815	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL3—Crohn's disease	3.09e-05	0.000812	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	3.04e-05	0.0008	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—ALB—Crohn's disease	3e-05	0.00079	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	3e-05	0.000788	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CXCL8—Crohn's disease	3e-05	0.000787	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	2.99e-05	0.000786	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.99e-05	0.000784	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	2.94e-05	0.000773	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTMR3—Crohn's disease	2.94e-05	0.000772	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCR6—Crohn's disease	2.82e-05	0.000741	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	2.76e-05	0.000725	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	2.72e-05	0.000715	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	2.6e-05	0.000682	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	2.59e-05	0.00068	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.59e-05	0.00068	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.58e-05	0.000678	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RBX1—Crohn's disease	2.55e-05	0.00067	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	2.55e-05	0.00067	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.54e-05	0.000667	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	2.51e-05	0.000659	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—FADS1—Crohn's disease	2.49e-05	0.000654	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	2.48e-05	0.000652	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR6—Crohn's disease	2.44e-05	0.000642	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR6—Crohn's disease	2.44e-05	0.00064	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	2.4e-05	0.00063	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	2.39e-05	0.000629	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	2.38e-05	0.000627	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	2.35e-05	0.000617	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GPX4—Crohn's disease	2.33e-05	0.000613	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—FADS1—Crohn's disease	2.29e-05	0.000602	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.26e-05	0.000594	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GCKR—Crohn's disease	2.25e-05	0.000592	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	2.24e-05	0.000587	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RBX1—Crohn's disease	2.21e-05	0.000581	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RBX1—Crohn's disease	2.2e-05	0.000579	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	2.17e-05	0.000571	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	2.17e-05	0.00057	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	2.17e-05	0.00057	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	2.17e-05	0.000569	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PTGER4—Crohn's disease	2.15e-05	0.000565	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GPX4—Crohn's disease	2.14e-05	0.000564	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	2.14e-05	0.000563	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	2.13e-05	0.00056	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL3—Crohn's disease	2.11e-05	0.000556	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	2.11e-05	0.000555	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GCKR—Crohn's disease	2.07e-05	0.000544	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	2.04e-05	0.000537	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	1.94e-05	0.000509	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	1.93e-05	0.000507	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.92e-05	0.000505	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	1.9e-05	0.000499	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RIPK2—Crohn's disease	1.88e-05	0.000494	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	1.87e-05	0.000492	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	1.86e-05	0.000488	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	1.85e-05	0.000487	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	1.84e-05	0.000484	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL3—Crohn's disease	1.83e-05	0.000481	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL3—Crohn's disease	1.83e-05	0.00048	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL3—Crohn's disease	1.8e-05	0.000472	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	1.77e-05	0.000466	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	1.77e-05	0.000464	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	1.77e-05	0.000464	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	1.74e-05	0.000457	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	1.69e-05	0.000445	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	1.69e-05	0.000443	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.61e-05	0.000423	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	1.61e-05	0.000422	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SOCS1—Crohn's disease	1.61e-05	0.000422	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	1.6e-05	0.000421	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	1.6e-05	0.00042	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	1.6e-05	0.00042	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	1.58e-05	0.000415	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	1.58e-05	0.000414	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	1.54e-05	0.000404	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—TYK2—Crohn's disease	1.53e-05	0.000402	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	1.53e-05	0.000401	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	1.5e-05	0.000395	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—FADS1—Crohn's disease	1.5e-05	0.000393	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	1.48e-05	0.000389	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	1.47e-05	0.000386	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	1.46e-05	0.000384	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—JAK2—Crohn's disease	1.46e-05	0.000384	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	1.46e-05	0.000382	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	1.44e-05	0.000378	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	1.43e-05	0.000376	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.41e-05	0.00037	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GPX4—Crohn's disease	1.4e-05	0.000368	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SMAD3—Crohn's disease	1.39e-05	0.000364	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	1.38e-05	0.000363	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	1.36e-05	0.000357	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCKR—Crohn's disease	1.35e-05	0.000356	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	1.33e-05	0.00035	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	1.33e-05	0.000349	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	1.31e-05	0.000344	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL2RA—Crohn's disease	1.28e-05	0.000337	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	1.28e-05	0.000336	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	1.26e-05	0.000331	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TYK2—Crohn's disease	1.04e-05	0.000274	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—JAK2—Crohn's disease	9.95e-06	0.000262	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	9.09e-06	0.000239	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TYK2—Crohn's disease	9.04e-06	0.000238	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TYK2—Crohn's disease	9.01e-06	0.000237	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	8.87e-06	0.000233	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—Crohn's disease	8.64e-06	0.000227	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—JAK2—Crohn's disease	8.63e-06	0.000227	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—JAK2—Crohn's disease	8.6e-06	0.000226	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	8.46e-06	0.000222	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL8—Crohn's disease	7.87e-06	0.000207	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	7.85e-06	0.000206	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	7.72e-06	0.000203	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—Crohn's disease	7.49e-06	0.000197	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—Crohn's disease	7.46e-06	0.000196	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	7.35e-06	0.000193	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—STAT3—Crohn's disease	7.31e-06	0.000192	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—Crohn's disease	7.17e-06	0.000188	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—Crohn's disease	6.59e-06	0.000173	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—STAT3—Crohn's disease	6.33e-06	0.000166	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—STAT3—Crohn's disease	6.31e-06	0.000166	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—Crohn's disease	6.27e-06	0.000165	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	6.21e-06	0.000163	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—Crohn's disease	5.77e-06	0.000152	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—Crohn's disease	5.1e-06	0.000134	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—Crohn's disease	4.42e-06	0.000116	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—Crohn's disease	4.41e-06	0.000116	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—Crohn's disease	4.34e-06	0.000114	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—Crohn's disease	4.31e-06	0.000113	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.77e-06	9.91e-05	CbGpPWpGaD
